| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/13/2009 | US7601815 For controlling development, differentiation, trafficking, and physiology of mammalian cells; diagnosis |
| 10/13/2009 | US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy |
| 10/13/2009 | US7601813 Anti-GL50 antibodies |
| 10/13/2009 | US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 10/13/2009 | US7601811 Bacillus thuringiensis gene with lepidopteran activity |
| 10/13/2009 | US7601810 insecticidal proteins encoded by naturally-occurring and recombinant nucleic acids, has the activity against plant pathogens |
| 10/13/2009 | US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 10/13/2009 | US7601808 molecular weight is 15863.79 Da; has higher drug potentiation than from the mycelium of G. lucidum |
| 10/13/2009 | US7601806 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression |
| 10/13/2009 | US7601805 Photoprotein with improved bioluminescence |
| 10/13/2009 | US7601804 immunogens for treating cattle diseases; biodrugs for veterinary medicine |
| 10/13/2009 | US7601803 mutagenized bovine gamma-II-crystallin polypeptide with binding to the Hormone Estradiol; antibodies, enzymes |
| 10/13/2009 | US7601802 Cysteine-containing peptides having antioxidant properties |
| 10/13/2009 | US7601801 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine |
| 10/13/2009 | US7601800 monitor a patient's response to glutamine supplementation undergoing radiation therapy; correlating the increase in the amount of serum proteins to the extent of protection of breast tissue against radiation injury |
| 10/13/2009 | US7601799 Methods and means to promote gut absorption |
| 10/13/2009 | US7601698 Polypeptide |
| 10/13/2009 | US7601697 Polypeptides; nucleic acid molecules and viral vectors which direct gene expression of such polypeptides; vaccines; genetic engineering; transfecting cells of animal ex vivo with nucleic acid molecule and delivering transfected cells animal |
| 10/13/2009 | US7601692 Monocyte Chemoattractant Protein 1 (MCP-1); useful to treat various MCP-1 related disorders as well as for diagnosing, determining predisposition and/or prognosis of various disorders |
| 10/13/2009 | US7601691 PYY peptide or a functional derivative, coupled to a reactive group( michael acceptor, maleimides or succnimides) capable of reacting on a blood component so as to form a stable covalent bond |
| 10/13/2009 | US7601689 Mixture comprising stabilized neovascularization protein; for use in management of hypertension, hyperlipidemia, diabetes and chronic fatigue syndrome |
| 10/13/2009 | US7601685 Comprises fusion proteins for use in microarray designed for tissue repair, regeneration and/or remodeling and/or drug delivery |
| 10/13/2009 | US7601684 Test strips; medical diagnosis |
| 10/13/2009 | US7601683 Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith |
| 10/13/2009 | US7601540 Gamma secretase notch biomarkers |
| 10/13/2009 | US7601531 Chlamydia pneumoniae polynucleotides and uses thereof |
| 10/13/2009 | US7601526 Purified FabI polypeptides from Fransicella tularensis |
| 10/13/2009 | US7601521 Detection of nucleic acid mutation associated with cancer by analysis of saliva |
| 10/13/2009 | US7601518 Secretion of neublastin |
| 10/13/2009 | US7601517 Split protein self complementing fragments, systems, and methods of use thereof |
| 10/13/2009 | US7601516 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders |
| 10/13/2009 | US7601515 Process of high purity albumin production |
| 10/13/2009 | US7601514 Encodes a polypeptide which inhibits the proliferation of T-lymphocytes; use in diagnosis and treatment of immune disorders; PRO polypeptides; autoimmune disorders |
| 10/13/2009 | US7601513 Recombinant methods for expressing a functional umami (T1R1/T1R3) taste receptor |
| 10/13/2009 | US7601510 Development and use of fluorescent probes of unbound analytes |
| 10/13/2009 | US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides |
| 10/13/2009 | US7601504 for use in immunoassay, replace albumin and casein which are linked to mad cow disease concerns; large scale E coli synthesis; modified DNAk (HSP70) protein |
| 10/13/2009 | US7601491 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| 10/13/2009 | US7601359 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins |
| 10/13/2009 | US7601353 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 10/13/2009 | US7601350 Antibodies that bind M. tuberculosis polypeptides |
| 10/13/2009 | US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein |
| 10/13/2009 | US7601343 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 10/13/2009 | US7601341 conjugate is cytotoxic to cells expressing more than 2000 type 2 VEGF receptors per celll fusion protein with cytotoxic molecule such as gelonin or granzyme B or Bax |
| 10/13/2009 | US7601201 Method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide |
| 10/13/2009 | CA2513296C Novel lysophosphatidic acid receptor |
| 10/13/2009 | CA2472373C Combination of paclitaxel and a polymer |
| 10/13/2009 | CA2356331C Methods for glucagon suppression |
| 10/13/2009 | CA2333598C Toxoplasma gondii antigens, p35, and uses thereof |
| 10/13/2009 | CA2309278C Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 10/13/2009 | CA2234263C Pharmaceutical composition for treating papillomavirus tumours and infection |
| 10/13/2009 | CA2222650C Tnf-.alpha. converting enzyme |
| 10/13/2009 | CA2103583C Recombinant transferrins, transferrin half-molecules and mutants thereof |
| 10/08/2009 | WO2009124135A2 Annexin-based apoptosis markers |
| 10/08/2009 | WO2009124055A1 Human apoa-i mutants |
| 10/08/2009 | WO2009123573A1 Anticoagulants derived from naja nigricollis snake venom |
| 10/08/2009 | WO2009123349A1 Method for proliferation of pluripotent stem cell |
| 10/08/2009 | WO2009123225A1 Composition, kit and method for detecting neuropathy |
| 10/08/2009 | WO2009123224A1 Composition, kit and method for detecting aging and disease associated with vascular disorder |
| 10/08/2009 | WO2009123162A1 Method for determination of edema associated with liver disease |
| 10/08/2009 | WO2009123145A1 Parasporin-1 receptor and use thereof |
| 10/08/2009 | WO2009123119A1 Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same |
| 10/08/2009 | WO2009123061A1 Purified serum albumin and immunological measurement method |
| 10/08/2009 | WO2009122994A1 Circularly polarized light-emitting nanoparticle |
| 10/08/2009 | WO2009121994A1 Fusion proteins having a beta-trefoil-type lectin domain, method for obtaining same and use thereof |
| 10/08/2009 | WO2009121921A1 Method for restoring an ejaculatory failure |
| 10/08/2009 | WO2009121897A1 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein |
| 10/08/2009 | WO2009121884A1 Insulin albumin conjugates |
| 10/08/2009 | WO2009121828A1 Use of defensins against meningitis |
| 10/08/2009 | WO2009121566A1 Mzb1, a novel b cell factor, and uses thereof |
| 10/08/2009 | WO2009121483A1 Highly bridged peptides from actinomadura namibiensis |
| 10/08/2009 | WO2009121210A1 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 10/08/2009 | WO2009121176A1 Insulin-induced gene (insig) peptide compositions and methods for cytoprotection |
| 10/08/2009 | WO2009101205A3 Immunogenic control of tumours and tumour cells |
| 10/08/2009 | WO2009101204A3 Elimination of immune responses to viral vectors |
| 10/08/2009 | WO2009094006A3 Bordetella outer-membrane protein antigens and methods of making and using the same |
| 10/08/2009 | WO2009092891A3 Modification of intrinsically disordered sequences for preparing vaccines |
| 10/08/2009 | WO2009091692A3 Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 10/08/2009 | WO2009088968A3 Engineered transglutaminase barrel proteins |
| 10/08/2009 | WO2009080806A3 Modified influenza virus |
| 10/08/2009 | WO2009077611A3 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
| 10/08/2009 | WO2009068588A3 Transgenic plants with increased stress tolerance and yield |
| 10/08/2009 | WO2007067410A3 Methods of in vitro propagation and detection of infectious prion |
| 10/08/2009 | WO2001098526A9 Receptor fingerprinting, sensory perception, and biosensors of chemical sensants |
| 10/08/2009 | WO2001025256A3 Trdl-1-gamma, a novel tumor necrosis-like ligand |
| 10/08/2009 | US20090255004 G-Protein Coupled Receptor and Uses Therefor |
| 10/08/2009 | US20090253898 Mathematical Design of ION Channel Selectivity Via Inverse Problem Technology |
| 10/08/2009 | US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 10/08/2009 | US20090253895 Printable Materials |
| 10/08/2009 | US20090253864 IL-21 Derivatives and Variants |
| 10/08/2009 | US20090253777 Methods of diagnosing and treating hyperproliferative disorders |
| 10/08/2009 | US20090253770 Target gene mimitin of myc |
| 10/08/2009 | US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue |
| 10/08/2009 | US20090253638 Somatostatin Antagonists |
| 10/08/2009 | US20090253635 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 10/08/2009 | US20090253630 Pegylated pth as pth receptor modulators and uses thereof |
| 10/08/2009 | US20090253629 Use of defensins against meningitis |
| 10/08/2009 | US20090253627 Lactoferrin compositions and methods of wound treatment |
| 10/08/2009 | US20090253626 50 Human Secreted Proteins |
| 10/08/2009 | US20090253625 GLP-1, exendin-4, peptide analogs and uses thereof |